The Brand Name IPSITA Has Generic Salt :: Candesartan
IPSITA Is From Company Bal Ph. Priced :: Rs. 56
IPSITA have Candesartan is comes under Sub class Anti Hypertensives of Main Class Cardiovascular System
Main Medicine Class:: Cardiovascular System Sub Medicine Class :: Anti Hypertensives
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Hypertension, Congestive heart failure
Drug Dose ::
Oral Hypertension Adult: Initially, 8 mg once daily adjusted according to response. Maintenance: 8 mg once daily. Max: 32 mg/day as single or in 2 divided doses. Patients w/ intravascular volume depletion: Initially, 4 mg once daily. Child: 1 to <6 yr initially, 200 mcg>6 yr <50 kg: 4-8 mg>50 kg: 8-16 mg/day, adjusted according response to 4-32 mg/day. All doses may be given as single or in 2 divided doses. Hepatic impairment: Mild to moderate: Initially, 4 mg once daily. Severe: Contraindicated. Heart failure Adult: Initially, 4 mg once daily, may be doubled at intervals of not <2 wk. max: 32 mg once daily. hepatic impairment: severe: contraindicated. Contraindication ::
Hypersensitivity. Pregnancy (2nd and 3rd trimester) and lactation.
Drug Precautions ::
Volume or sodium depletion, preexisting renal insufficiency; aortic or mitral valve stenosis, hypertrophic obstructive cardiomyopathy, renal artery stenosis, primary hyperaldosteronism. Patients with a history of angioedema, urticaria. Monitor serum potassium levels especially in elderly and renally impaired patients. Hypotension may occur during major surgery and anaesthesia due to suppression of the renin-angiotensin system.
Drug Side Effects ::
Dizziness, headache, vertigo, depression, somnolence, fever, back pain, upper respiratory tract infections, 1st dose orthostatic hypotension, rash, diarrhoea, decreased haemoglobin, renal impairment, hepatitis.
Pregnancy category ::
Drug Mode of Action ::
Candesartan inhibits the binding of angiotensin II to AT1 receptors in many tissues (e.g. vascular smooth muscles, adrenal gland) which leads to vasoconstriction blockade and aldosterone release.
Drug Interactions ::
NSAIDs may reduce antihypertensive effect and result in deterioration of renal function including possible acute renal failure. May increase serum lithium concentration. K-sparing diuretics, K supplements or salt substitutes containing K may increase risk of hyperkalaemia. Potentially Fatal: Coadministration w/ aliskiren in diabetic patients may increase risk of renal impairment, hypotension and hyperkalaemia.